A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder

Bipolar Disorders

Volumn 8, Issue 5 II, 2006, Pages 543-550

  Sher, Leo ^a   Carballo, Juan J ^a   Grunebaum, Michael F ^a   Burke, Ainsley K ^a   Zalsman, Gil ^a   Huang, Yung Yu ^a   Mann, J John ^a   Oquendo, Maria A ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

3 methoxy 4 hydroxyphenylglycol; 5 hydroxyindolacetic acid; Bipolar; Cerebrospinal fluid; Homovanillic acid; Lethality; Suicide

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID;

ADULT; AGGRESSION; ARTICLE; BIPOLAR DEPRESSION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMOGRAPHY; ELECTROCHEMICAL DETECTION; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL DISCHARGE; HOSTILITY; HUMAN; HYPOTHESIS; INTERVIEW; LETHALITY; LUMBAR PUNCTURE; MALE; MONOAMINE METABOLISM; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; BIPOLAR DISORDER; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; PREFRONTAL CORTEX; PREVALENCE; PROSPECTIVE STUDIES; SUICIDE; SUICIDE, ATTEMPTED;

EID: 33749990607     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2006.00319.x     Document Type: Article

References (73)

1. Center for Disease Control, National Center for Injury Prevention and Control. Suicide in the United States [WWW document]. URL http://www.cdc.gov/ncipc/factsheets/suifacts.htm [accessed on 14 March 2005], 2002.
2. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: A reexamination. Am J Psychiatry 2000; 157: 1925-1932.
3. Mitchell PB, Malhi GS. Bipolar depression: Phenomenological overview and clinical characteristics. Bipolar Disord 2004; 6: 530-539.
4. Oquendo MA, Galfalvy H, Russo S et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004; 161: 1433-1441.
5. Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: Risk and prevention. CNS Drugs 2003; 17: 491-511.
6. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol Psychiatry 1996; 39: 896-899.
7. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
8. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228.
9. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 1997; 73: 47-56.
10. Ferrier IN. Treatment of major depression: Is improvement enough? J Clin Psychiatry 1999; 60 (Suppl. 6): 10-14.
11. Isometsa ET, Henriksson MM, Aro HM, Lonnqvist JK. Suicide in bipolar disorder in Finland. Am J Psychiatry 1994; 151: 1020-1024.
12. Lopez P, Mosquera F, de Leon J et al. Suicide attempts in bipolar patients. J Clin Psychiatry 2001; 62: 963-966.
13. Beautrais AL. Suicide and serious suicide attempts in youth: A multiple-group comparison study. Am J Psychiatry 2003; 160: 1093-1099.
14. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996; 168: 324-329.
15. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4: 819-828.
16. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000; 23: 11-25.
17. Sher L, Mann JJ. Neurobiology of suicide. In: Soares JC, Gershon S eds. Textbook of Medical Psychiatry. New York: Marcel Dekker, 2003: 701-711.
18. van Heeringen K. The neurobiology of suicide and suicidality. Can J Psychiatry 2003; 48: 292-300.
19. Papeschi R, Sourkes TL, Poirier LJ, Boucher R. On the intracerebral origin of homovanillic acid of the cerebrospinal fluid of experimental animals. Brain Res 1971; 28: 527-533.
20. Stanley M, Traskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 1985; 37: 1279-1286.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: APA Press, 1994.
22. Hamilton MA. Rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
23. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1996; 4: 561-571.
24. Brown GL, Goodwin FK. Human aggression and suicide. Suicide Life Threat Behav 1986; 16: 223-243.
25. Barrat ES. Factor analysis of some psychometrics measures of impulsiveness and anxiety. Psychol Rep 1965; 16: 547-554.
26. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957; 21: 343-349.
27. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol 1974; 42: 861-865.
28. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: The Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47: 343-352.
29. Oquendo MA, Halberstam B, Mann JJ. Risk factors for suicidal behavior: utility and limitations of research instruments. In: First MB ed. Standardized Evaluation in Clinical Practice, Vol. 22. Washington, DC: APPI Press, 2003: 103-130.
30. Beck AT, Beck R, Kovacs M. Classification of suicidal behaviors: I. Quantifying intent and medical lethality. Am J Psychiatry 1975; 132: 285-287.
31. Beck RW, Morris JB, Beck AT. Cross-validation of the Suicidal Intent Scale. Psychol Rep 1974; 34: 445-446.
32. Scheinin M, Chang WH, Kirk KL, Linnoila M. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Anal Biochem 1983; 131: 246-253.
33. Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry 2003; 160: 773-779.
34. Duggan CF, Sham P, Lee AS, Murray RM. Can future suicidal behaviour in depressed patients be predicted? J Affect Disord 1991; 22: 111-118.
35. Fawcett J, Scheftner WA, Fogg L et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990; 147: 1189-1194.
36. Nordstrom P, Asberg M, Aberg-Wistedt A, Nordin C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand 1995; 92: 345-350.
37. Angst J, Clayton PJ. Personality, smoking and suicide: A prospective study. J Affect Disord 1998; 51: 55-62.
38. Coccaro EF, Siever LJ, Klar HM et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46: 587-599.
39. Corbitt EM, Malone KM, Haas GL, Mann JJ. Suicidal behavior in patients with major depression and comorbid personality disorders. J Affect Disord 1996; 39: 61-72.
40. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983; 33: 2609-2614.
41. Malone KM, Haas GL, Sweeney JA, Mann JJ. Major depression and the risk of attempted suicide. J Affect Disord 1995; 34: 173-185.
42. Oquendo MA, Waternaux C, Brodsky B et al. Suicidal behavior in bipolar mood disorder: Clinical characteristics of attempters and nonattempters. J Affect Disord 2000; 59: 107-117.
43. Sher L, Oquendo MA, Mann JJ. Risk of suicide in mood disorders. Clin Neurosci 2001; 1: 337-344.
44. Sher L, Oquendo MA, Galfalvy HC et al. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict Behav 2005; 30: 1144-1153.
45. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1979; 1: 131-139.
46. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999; 156: 181-189.
47. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995; 688: 121-133.
48. Mann JJ, Henteleff RA, Lagattuta TF, Perper JA, Li S, Arango V. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. J Neural Transm 1996; 103: 1337-1350.
49. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983; 1: 214-216.
50. Mann JJ, Arango V. Neurobiology of suicidal behavior. In: Wasserman D ed. Suicide: An Unnecessary Death. London: Martin Dunitz Ltd, 2001: 29-34.
51. Pandey GN, Dwivedi Y, Rizavi HS et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002; 159: 419-429.
52. Mann JJ, Marzuk PM, Arango V, McBride PA, Leon AC, Tierney H. Neurochemical studies of violent and nonviolent suicide. Psychopharmacol Bull 1989; 25: 407-413.
53. Asberg M, Nordstrom P, Traskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 1986; 487: 243-255.
54. Mann JJ, Malone KM, Psych MR et al. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 1996; 15: 576-586.
55. Cooper SJ, Kelly CB, King DJ. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 1992; 340: 940-941.
56. Nordstrom P, Samuelsson M, Asberg M et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994; 24: 1-9.
57. Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 1995; 13: 53-64.
58. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 1997; 41: 162-171.
59. Oquendo MA, Placidi GP, Malone KM et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003; 60: 14-22.
60. Jones JS, Stanley B, Mann JJ et al. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990; 147: 1225-1227.
61. Roy A, Agren H, Pickar D et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry 1986; 143: 1539-1545.
62. Sher L, Mann JJ, Traskman-Bendz L, Huang Y, Stanley B. Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. Biol Psychiatry 2005; 57: 134S.
63. Traskman L, Asberg M, Bertilsson L, Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981; 38: 631-636.
64. Engstrom G, Alling C, Blennow K, Regnell G, Traskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 1999; 9: 399-405.
65. Agren H. Life at risk: Markers of suicidality in depression. Psychiatr Dev 1983; 1: 87-103.
66. Montgomery SA, Montgomery D. Pharmacological prevention of suicidal behaviour. J Affect Disord 1982; 4: 291-298.
67. Roy A, De Jong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 1989; 46: 609-612.
68. Traskman-Bendz L, Alling C, Alsen M, Regnell G, Simonsson P, Ohman R. The role of monoamines in suicidal behavior. Acta Psychiatr Scand 1993; 371 (Suppl.): 45-47.
69. Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results. Biol Psychiatry 1996; 39: 112-120.
70. Ordway GA, Widdowson PS, Smith KS, Halaris A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem 1994; 63: 617-624.
71. Agren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide. Psychiatry Res 1980; 3: 225-236.
72. Sher L, Mann JJ. Psychiatric pathophysiology: Mood disorders. In: Tasman A, Kay J, Lieberman JA eds. Psychiatry. Chichester, UK: John Wiley & Sons, 2003: 300-315.
73. Berns GS, Nemeroff CB. The neurobiology of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123: 76-84.